|
| 6-Methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-3,4-dihydroquinazolin-4-one Basic information |
Product Name: | 6-Methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-3,4-dihydroquinazolin-4-one | Synonyms: | 6-Methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-3,4-dihydroquinazolin-4-one;vandetanib interMediate;7-((1-Methylpiperidin-4-yl)Methoxy)-6-Methoxyquinazolin-4(3H)-one;6-Methoxy-7-((1-Methylpiperidin-4-yl)Methoxy)quinazolin-4(3H)-one;6-Methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-3,4-dihydroquinazolin-4-one###264208-69-7;6-Methoxy-7-(N-methylpiperidin-4-ylmethoxy)-3,4-dihydroquinazolin-4-one;4(3H)-Quinazolinone, 6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-;Vandetanib 4-Hydroxy Impurity | CAS: | 264208-69-7 | MF: | C16H21N3O3 | MW: | 303.36 | EINECS: | | Product Categories: | | Mol File: | 264208-69-7.mol | |
| 6-Methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-3,4-dihydroquinazolin-4-one Chemical Properties |
Boiling point | 465.7±55.0 °C(Predicted) | density | 1.29±0.1 g/cm3(Predicted) | pka | 9.04±0.10(Predicted) |
| 6-Methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-3,4-dihydroquinazolin-4-one Usage And Synthesis |
| 6-Methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-3,4-dihydroquinazolin-4-one Preparation Products And Raw materials |
|